Rosario García-Campelo

机构：Universidade da Coruña, Complexo Hospitalario Universitario A Coruña, Servicio Gallego de Salud, Instituto de Investigación Biomédica de A Coruña · ORCID：0000-0003-2113-1504

发表论文 37 篇 · 总被引 403 次 · h-index 8

代表论文

• Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial (2025 · Nature Medicine · 被引 35)
• Expert Consensus on the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung Cancer (2024 · Clinical Drug Investigation · 被引 14)
• Peripheral memory B cell population maintenance and long-term survival after perioperative chemoimmunotherapy in NSCLC (NADIM trial) (2025 · OncoImmunology · 被引 7)
• First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study (2024 · Frontiers in Oncology · 被引 7)
• Multidisciplinary approach for patients with early and locally advanced non-small cell lung cancer (NSCLC): 2nd Spanish Lung Cancer Group (GECP) expert consensus statement (2025 · Translational Lung Cancer Research · 被引 6)
• Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysis (2024 · Journal of Medical Economics · 被引 6)